Topics:

News

News

Among five physicians on a new panel responsible for monitoring compounding pharmacies, the industry representative has a long history in rheumatology.

(OPINION) A rheumatologist in solo private practice in an under-served area offers his prescription for protecting patients' interests in sound medical care as well as the time, professional obligations, and public image of physicians.

In 96-week extension data from a Phase 3 trial the tumor necrosis factor (TNF) inhibitor shows sustained improvements in symptoms of spondyloarthropathies, with no signs of new adverse events.

The firm Cadila is launching its biosimilar Exemptia in India for about 1/5 the price tag of Abbot's Humira. Most biosimilars to date are sold at roughly two-thirds the cost of the FDA-approved versions.

A small controlled trial, first rigorous test of the question, shows that self-massage with a foam roller can substantially reduce soreness in the quadriceps after exercise.

MRI proves itself as a valuable tool for pinpointing inflammatory and structural damage in select rheumatoid arthritis patients.

New data boosts confidence in drug therapies for osteoporosis, but more research in older adults is required.

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.